Sex Differences in Medication Discontinuation in Axial Spondyloarthritis
In a large US registry, women with axSpA were more likely to discontinue TNFi and IL-17i than men. Larger studies with longer follow-up since treatment approval are needed to confirm the lack of sex differences in JAKi discontinuation as this group could be underpowered.
Authors
- Katherine D. Wysham (ORCID: https://orcid.org/0000-0001-8707-7649)
- Namrata Singh (ORCID: https://orcid.org/0000-0001-7149-363X)
- Jinoos Yazdany (ORCID: https://orcid.org/0000-0002-3508-4094)
- Lianne S. Gensler (ORCID: https://orcid.org/0000-0001-6314-5336)
- Gabriela Schmajuk (ORCID: https://orcid.org/0000-0003-2687-5043)
- Rachael Stovall (ORCID: https://orcid.org/0000-0002-0355-4020)
- Eric T. Roberts (ORCID: https://orcid.org/0009-0005-8435-8994)
- Cinthia Blat
- Jean W. Liew (ORCID: https://orcid.org/0000-0002-8104-2450)
- Janna Friedly (ORCID: https://orcid.org/0000-0002-7483-7888)
Institutions
- Boston University (US)
- Public Policy Institute of California (US)
- University of California, San Francisco (US)
- University of Washington (US)
- VA Puget Sound Health Care System (US)
- San Francisco VA Health Care System (US)
- Seattle University (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1002/acr.70001
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Rheumatology Research Foundation
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases